Flora Peyvandi Shares BIC 2025 Coverage of Hemostasis & Thrombosis: 10 Posts Not To Miss
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared on X:
Flora Peyvandi shared BIC 2025 Coverage of latest research on Hemostasis and Thrombosis fresh from the conference:
1.‘‘Wolfgang Miesbach reports the safety of HA and HB gene therapies after 5 and 4 years respectively”
2.”David Lilicrap reports the interindividual variability of gene therapy in Hemophilia at BIC2025”
3.‘‘David Lilicrap reports data on long term safety of HA gene therapy”
4.”Alessio Cantore at Bic 2025 reporting where we are standing with lentiviral gene therapy in Hemophilia”
5.”Naldini group showed clearly they are ready to go through clinical trial phase 1 for HB with lenti viral vector and what’s missing is Funding.
Why that’s happening? No more interest in GT in Hemophilia even for the cure?”
6.”Very interesting data on gene therapy as the ITI to reverse the anti factor inhibitors in mice with anti FIX inhibitors was successful bic 2025.
Data from Dr Herzog Indiana University”
7.”New gene therapy clinical trial on FVII severe deficiency by Amit Nathwani. Look forward for that!”
8.”Amy Shapiro reports a new DDAP molecule to treat patients with VWD type 1.
This is a great news due to discontinuation of intranasal Desmopressin and it shortage.
This formulation is available in US”
9.”A single dose of VGA039 in 10 patients with VWD inhibiting PS , showed good efficacy with no safety issue reported by Carolyn Millar”
10.”Michela Milani should how they created a shielded lentiviral vector to reduce the immunogenicity against FVIII in mice”
More from BIC 2025 featured in Hemostasis Today.
-
Dec 19, 2025, 06:13Anna Aldehag Reflects on Her 12 Year Leadership in Sweden National Board of Health and Welfare
-
Dec 19, 2025, 05:54Abdul Mannan: APTT Mixing Studies Confuse a Lot of People
-
Dec 18, 2025, 23:14The “Normal” FVIII Level Trap in Females with Haemophilia
-
Dec 18, 2025, 23:11WFH Expands Multidisciplinary Bleeding Disorder Training in Vietnam
-
Dec 18, 2025, 17:13Daria Camilli on EuroBloodNet and EHC Collaboration for Bleeding Disorders
-
Dec 18, 2025, 16:50Marie Cambot on Innovhem’s Quantification of The HbF/HbS Ratio for SCD
-
Dec 18, 2025, 16:26Yogesh Rathod on Hematological Issues and ICU
-
Dec 18, 2025, 16:09Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
-
Dec 18, 2025, 15:23Michael Hadley: Well-Timed ACC Statement Just Out in JACC Journals